Galbraith Kenneth Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1.5M
Insider Sells Quantity
4
Insider Sells Sum
$1.3M

Insider Activity of Galbraith Kenneth

According to the SEC Form 4 filings, Galbraith Kenneth, being in a position of

  1. Chair & CEO at Zymeworks Inc.,
    оver the last 12 months, has bought 0 shares, and sold 132295 shares for $3.34M,
    over all time since 2024-01-05, has bought 0 shares, and sold 213490 shares for $4.45M.

Biography of Galbraith Kenneth

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,337,9713100

Comparison of Insiders on Amount of Buys and Sells

2026-01-12SaleZymeworks Inc.
ZYME
Chair & CEO
30,424
0.0396%
$22.67$689,819+7.66%
2026-01-05SaleZymeworks Inc.
ZYME
Chair & CEO
54,343
0.0712%
$25.10$1.36M-2.51%
2025-12-22SaleZymeworks Inc.
ZYME
Chair & CEO
47,528
0.0618%
$27.02$1.28M-9.38%
2025-01-06SaleZymeworks Inc.
ZYME
Chair & CEO
57,291
0.0847%
$14.92$855,017-2.56%
2024-01-08SaleZymeworks Inc.
ZYME
Chair & CEO
5,706
0.0079%
$11.22$63,996-5.03%
2024-01-05SaleZymeworks Inc.
ZYME
Chair & CEO
18,198
0.0262%
$10.65$193,849+3.36%
2020-09-09SaleMacroGenics, Inc.
MGNX
director
6,924
0.0127%
$27.11$187,710-8.85%
2013-10-16PurchaseMacroGenics, Inc.
MGNX
director
93,750
0.2246%
$16.00$1.5M-11.58%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.